Cases of swine flu, also known as Influenza A or H1N1, have been increasingly getting reported. On Tuesday, Justice D Y Chandrachud revealed that few Supreme Court judges are down with H1N1

Ever since India changed its intellectual property laws in 2005 to permit product patents in India, the country has been increasingly granting patents

Syngene International Limited, a leading global contract research organisation, announced the commissioning of the first phase of its new R&D centre in Hyderabad

Coronavirus in China: Hubei in China is a major supplier of the raw material- API used in several medical formulations. In order to decide a course of action, the government is likely to consult an 8-member panel

Unichem is recalling 1.91 crore units of Clonidine Hydrochloride tablets and Macleods is recalling 4,694 bottles of Pioglitazone and Metformin Hydrochloride tablets used for treating high BP

The deal will enable adequate liquidity for robust growth in international operations and investments in Biosimilars for the US market; augment the remaining domestic branded business portfolio of the company and re-focus towards chronic segment with differentiated product portfolio, according to Wockhardt

Coronavirus: Antibiotics do not work against viruses, they only work on bacterial infections. The novel coronavirus is a virus and, therefore, antibiotics should not be used as a means of prevention or treatment

Greater investment in biological sciences is crucial because we are in times when both non-communicable diseases (like cancer and diabetes) and infectious diseases (caused by new viruses) are only going to rise

IRDAI recently has given approval to 19 innovative health insurance products under sandbox that will cater to specific needs of customers

True North will invest Rs 536.25 crore for a 2.44 per cent minority stake in Biocon Biologics India, taking its value to Rs 21,450 crore, or around $3 billion

Most in the Indian pharma industry are hopeful that the new National List of Essential Medicines (NLEM) expected in 2020 will not be too disruptive

The Prohibition of Electronic Cigarettes Act, 2019 was notified on December 6 making the production, import, export, transport, sale or advertisements of such \"alternative\" smoking devices a cognisable offence attracting jail term and fine

Tata Group Chairman N. Chandrasekaran's passion for running the toughest races is a legend of sorts

Industry watchers, however, say that it may lead to some pharma players opting more for medicines not falling under the drug price control regime

According to the report 'India: the emerging hub for biologics and biosimilars', the Indian pharmaceutical companies have launched 123 biosimilars and currently have 201 active biosimilars covering multiple indications in the development pipeline

Anti-diabetic drug Vildagliptin has witnessed a strong uptake in India for the last couple of years and are currently available across the country

Stocks in the news: YES Bank, Cipla, Magma Fincorp, JM Financial, Shriram Transport among others are the top stocks to watch out for Tuesday's trading session

Mental health in India is a huge stigma. People openly share with their friends and colleagues if they suffer from lifestyle diseases such as diabetes, but they refrain from sharing that they are feeling symptoms of depression or anxiety

Bhaskar Bhat's parting gift to Titan is handing over a far more valuable business

\"India is seeing a rise in digital transactions, and therefore industries are ramping up investments in Blockchain,\" says Ruchee Anand of LinkedIn